Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Protocol ID
ACT001-AU-002
Disease (Sub Disease)
Advanced brain tumour
Advanced solid tumour
Diagnosis Stage
Relapse/refractory
Location
NSW, QLD
Sponsor
Accendatech AU Pty Ltd
CPR Pharma Services Pty Ltd
Trial Status
Open
Sites
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 21 Years
ANZCTR
ACTRN12618001934235
Back to Registry
Study Title A study to evaluate the safety and tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumors
Protocol ID ACT001-AU-002
Disease (Sub Disease) Advanced brain tumour
Advanced solid tumour
Diagnosis Stage Relapse/refractory
Location NSW / QLD
Sponsor Accendatech AU Pty Ltd / CPR Pharma Services Pty Ltd/
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376262&isReview=true
Trial Status Open
Trial Open Date 18/09/2019
Sites Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital/
Study Type Treatment
Phase Phase 1
Age Eligibility 1 Year to 21 Years
ANZCTR ACTRN12618001934235